Ginkgo Bioworks Inc.

NYSE: DNA · Real-Time Price · USD
13.15
0.25 (1.94%)
At close: Aug 15, 2025, 3:59 PM
12.97
-1.37%
After-hours: Aug 15, 2025, 07:43 PM EDT

Ginkgo Bioworks Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
230.81M 237.42M 227.04M 217.95M 184.34M 208.7M 251.46M 314.99M 325.95M 390M 477.71M 527.91M 539.13M 438.14M 313.84M 197.4M 133.09M 99.62M
Cost of Revenue
41.1M 45.38M 55.4M 61.73M 58.66M 63.04M 63.34M 77.61M 95.34M 141.16M 204.22M 240.58M 238.22M 191.42M 129.69M 76.95M 56.42M 39.31M
Gross Profit
189.72M 192.04M 171.64M 156.22M 125.67M 145.66M 188.11M 237.37M 230.61M 248.84M 273.49M 287.34M 300.9M 246.72M 184.15M 120.45M 76.67M 60.31M
Operating Income
-313.32M -470.72M -540.49M -591.34M -822.53M -783.74M -840.74M -920.8M -1.29B -1.75B -2.21B -3.66B -3.03B -2.45B -1.83B -199.62M -207.36M -178.47M
Interest Income
28.75M 32.98M 38.61M 44.58M 50.35M 54.38M 57.22M 56.97M 47.77M 35.69M 21.32M 8.76M 3.06M 794K 617K 121K 3.32M 3.49M
Pretax Income
-316.09M -472.5M -547.51M -651.54M -897.68M -853.93M -892.94M -869.97M -1.24B -1.73B -2.12B -3.54B -2.97B -2.36B -1.84B -278.83M -202.34M -176.17M
Net Income
-315.19M -472.07M -547.03M -651.19M -897.68M -853.81M -892.87M -857.72M -1.22B -1.72B -2.11B -3.53B -2.96B -2.35B -1.83B -276.31M -200.49M -175.21M
Selling & General & Admin
201.91M 224.92M 226.9M 235.16M 264.89M 300.95M 361.36M 417.22M 770.38M 1.11B 1.43B 2.09B 1.68B 1.28B 862.95M 94.24M 75.16M 49.66M
Research & Development
277.68M 358.53M 411.19M 442.52M 522.17M 532.23M 571.28M 644.74M 747.66M 892.56M 1.05B 1.86B 1.65B 1.41B 1.15B 225.83M 208.88M 189.12M
Other Expenses
23.45M 79.32M 74.05M 69.89M 161.13M 96.21M 96.21M 96.21M -957K -1.01M 629K -988K -31K 20K -1.62M n/a n/a n/a
Operating Expenses
503.04M 662.76M 712.13M 747.56M 948.2M 929.39M 1.03B 1.16B 1.52B 2B 2.48B 3.95B 3.33B 2.69B 2.01B 320.07M 284.03M 236.28M
Interest Expense
94K 94K 94K 93K 93K 93K 93K 13.06M 14.73M 14.73M 15.13M 2.62M 1.6M 1.6M 1.68M 1.12M 1.07M 1.07M
Selling & Marketing Expenses
n/a n/a -19.27M -42.93M -42.93M -42.93M -23.66M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
544.13M 708.14M 786.8M 852.22M 1.05B 1.04B 1.12B 1.24B 1.61B 2.14B 2.69B 4.19B 3.57B 2.88B 2.14B 397.02M 340.45M 275.59M
Income Tax Expense
-895K -422K -479K -352K 1K -122K -71K -14.64M -14.65M -14.76M -15.03M -940K -1.12M -1.5M -1.48M -789K -576K -139K
Shares Outstanding (Basic)
54.86M 54.24M 51.89M 52.24M 51.33M 49.93M 49.11M 48.77M 48.14M 47.77M 45.6M 40.77M 40.52M 39.9M 36.94M 33.09M 32.31M 32.26M
Shares Outstanding (Diluted)
54.86M 54.24M 51.89M 52.25M 51.38M 49.99M 49.47M 48.77M 48.34M 47.92M 46.42M 40.77M 40.52M 40.19M 38.29M 33.09M 32.31M 32.26M
EPS (Basic)
-5.93 -9.06 -10.7 -12.91 -18.04 -17.4 -18.36 -17.86 -28.09 -41.01 -51.42 -89.46 -76.1 -61.26 -48.85 -8.49 -6.22 -5.49
EPS (Diluted)
-5.93 -9.06 -10.7 -12.94 -18.07 -17.44 -18.41 -17.95 -28.18 -41.09 -51.6 -91.09 -77.73 -62.89 -50.37 -8.51 -6.24 -5.51
EBITDA
-312.44M -446.56M -543.36M -598.84M -732.88M -699.72M -731.37M -688.3M -1.17B -1.64B -2.11B -3.55B -2.92B -2.33B -1.72B -173.94M -178.15M -153.25M
EBIT
-359.96M -457.4M -547.41M -691.05M -828.97M -855.1M -892.85M -736.93M -1.2B -1.67B -2.12B -3.58B -2.95B -2.37B -1.75B -199.62M -198.48M -169.59M
Depreciation & Amortization
63.98M 65.52M 63.02M 60.2M 64.1M 72.71M 86.83M 107.03M 95.47M 79.14M 61.63M 36.6M 35.38M 32.94M 29.08M 25.08M 20.32M 16.34M